In what represents a historical milestone in genetic engineering, Colossal Biosciences has successfully brought back the dire wolf (Aenocyon dirus) after 12,000 years of extinction. This achievement involved an unprecedented fusion of ancient DNA analysis, CRISPR gene editing, and cloning techniques to recreate a species once thought lost to time.
The technical achievement is particularly significant in its scale: Colossal’s scientists made 20 precise genomic edits to recreate the dire wolf—the highest number of deliberate genome edits in any animal to date. This surpasses their previous record of 8 edits in the “woolly mouse” with mammoth genes, demonstrating a remarkable leap forward in precision germline engineering.
“This news comes on the heels of the recent announcement of the Colossal woolly mouse, which previously held the record for unique germline edits in an animal with 8 precision edits. With the dire wolves, Colossal has made 20 unique precision germline edits including 15 edits from the ancient gene variants that have not existed in over 12,000 years, setting a new bar for precision germline editing in any animal,” noted Colossal in their announcement.
The process began with obtaining genetic material from fossil specimens—a 13,000-year-old tooth from Sheridan Pit, Ohio, and a 72,000-year-old inner ear bone from American Falls, Idaho. Using advanced DNA extraction and sequencing techniques, Colossal’s team was able to recover and analyze ancient DNA fragments from these remains.
Through computational analysis, the team assembled a high-quality genome, providing more than 500 times more coverage of the dire wolf genome than was previously available. This detailed genetic blueprint allowed researchers to identify the key genes that give dire wolves their characteristic features.
The team identified 14 important genes with 20 distinct genetic variants influencing traits such as the dire wolf’s larger size, more muscular build, wider skull, bigger teeth, thick light-colored coat, and unique howling vocalizations. These included variants in genes like CORIN, which influences coat color and patterning, and a multi-gene regulatory module linked to body size and skull morphology.
With this genetic roadmap, Colossal scientists used CRISPR to edit living cells from gray wolves—the dire wolf’s closest living relative, sharing 99.5% of their DNA. Rather than invasively harvesting tissue, they drew blood from living gray wolves and isolated endothelial progenitor cells (EPCs). This non-invasive blood sampling technique represents an important innovation for conservation applications.
Dr. George Church, Harvard geneticist and Colossal co-founder, explained the significance: “Preserving, expanding, and testing genetic diversity should be done well before important endangered animal species like the red wolf are lost. Another source of ecosystem variety stems from our new technologies to de-extinct lost genes, including deep ancient DNA sequencing, polyphyletic trait analyses, multiplex germline editing, and cloning. The dire wolf is an early example of this, including the largest number of precise genomic edits in a healthy vertebrate so far—a capability that is growing exponentially.”
After precise gene editing, the modified cell nuclei were transferred into egg cells through somatic cell nuclear transfer—the same cloning technique used to create Dolly the sheep. These reconstructed eggs were developed into embryos in the laboratory and then implanted into surrogate mother dogs (hound mixes) for gestation.
The careful approach to genetic editing demonstrates sophisticated bioinformatics analysis. For example, when engineering the dire wolf’s white coat color, the team avoided potential harmful side effects by choosing genetic pathways known to be safe in gray wolves—inducing loss-of-function to MC1R and MFSD12 genes rather than directly copying the dire wolf’s original pigmentation genes, which might have caused deafness or other issues.
“When I learned of Colossal’s approach to engineering the light coat color into their dire wolves, I was simultaneously impressed and relieved,” said Elinor Karlsson, Associate Professor at UMass Chan Medical School. “By choosing to engineer in variants that have already passed evolution’s clinical trial, Colossal is demonstrating their dedication to an ethical approach to de-extinction.”
The successful birth of three healthy dire wolf pups demonstrates that complex ancient traits can be resurrected in living, breathing creatures. This achievement validates Colossal’s end-to-end de-extinction technology and suggests that more ambitious projects—like bringing back the woolly mammoth—may indeed be feasible.
Beyond the dire wolf itself, the technologies developed have immediate applications for endangered species conservation. The novel approach of isolating and cloning expandable endothelial progenitor cells (EPCs) from simple blood draws provides a valuable opportunity to preserve genomic diversity in threatened species without invasive procedures.
As Colossal moves forward from this milestone, the technical breakthroughs achieved with the dire wolf project offer new tools for genetic rescue, biobanking, and veterinary innovations that could help preserve Earth’s biodiversity in the face of accelerating extinction rates.
